Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 148.00
+5.00 (3.50%)
Oct 9, 2025, 3:00 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 23.21 billion as of October 10, 2025. Its market cap has increased by 106.97% in one year.
Market Cap
23.21B
Enterprise Value
20.42B
Revenue
1.34B
Ranking
n/a
PE Ratio
34.96
Stock Price
148.00
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 23.21B, an increase of 179.06%. That is a compound annual growth rate of 12.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 23.21B | 119.50% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | 2.82B | -18.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |